Shareholders Led by Yi Zhang Announce Successful Results of Removal of Directors and Election of New Directors of YS Biopharma Co., Ltd.
Yi Zhang thanks his fellow shareholders for their support in achieving this positive outcome today.
- Yi Zhang thanks his fellow shareholders for their support in achieving this positive outcome today.
- The actions taken reflect an overwhelming shareholder repudiation of the prior board of directors of the Company (the "Board") and the total disregard for shareholder perspectives shown by the prior Board and management team.
- Given the result of the vote, Yi Zhang is confident that YS will now be able to focus its full efforts on executing its business strategy and preserving and growing long-term value for all shareholders.
- These statements involve risks, uncertainties and other factors that may cause actual results, events or achievements to differ materially from the information expressed or implied by these statements.